These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37766787)

  • 21. Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
    Havlicek S; Kohl Z; Mishra HK; Prots I; Eberhardt E; Denguir N; Wend H; Plötz S; Boyer L; Marchetto MC; Aigner S; Sticht H; Groemer TW; Hehr U; Lampert A; Schlötzer-Schrehardt U; Winkler J; Gage FH; Winner B
    Hum Mol Genet; 2014 May; 23(10):2527-41. PubMed ID: 24381312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring Axonal Degeneration in Human Pluripotent Stem Cell Models of Hereditary Spastic Paraplegias.
    Li XJ; Mou Y; Milton C; Chen Z
    Methods Mol Biol; 2022; 2549():69-83. PubMed ID: 33772460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients.
    Schlipf NA; Schüle R; Klimpe S; Karle KN; Synofzik M; Schicks J; Riess O; Schöls L; Bauer P
    Clin Genet; 2011 Aug; 80(2):148-60. PubMed ID: 21623769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency.
    Montoro-Gámez C; Nolte H; Molinié T; Evangelista G; Tröder SE; Barth E; Popovic M; Trifunovic A; Zevnik B; Langer T; Rugarli EI
    Brain; 2023 Oct; 146(10):4117-4131. PubMed ID: 37086482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia.
    Wilkinson PA; Crosby AH; Turner C; Bradley LJ; Ginsberg L; Wood NW; Schapira AH; Warner TT
    Brain; 2004 May; 127(Pt 5):973-80. PubMed ID: 14985266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric rapid screening of neuronal process pathology for drug target identification in HSP patient-specific neurons.
    Rehbach K; Kesavan J; Hauser S; Ritzenhofen S; Jungverdorben J; Schüle R; Schöls L; Peitz M; Brüstle O
    Sci Rep; 2019 Jul; 9(1):9615. PubMed ID: 31270336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia.
    Costamagna D; Casters V; Beltrà M; Sampaolesi M; Van Campenhout A; Ortibus E; Desloovere K; Duelen R
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced acetylated α-tubulin in
    Wali G; Siow SF; Liyanage E; Kumar KR; Mackay-Sim A; Sue CM
    Front Neurosci; 2023; 17():1073516. PubMed ID: 37144097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse brain expression patterns of Spg7, Afg3l1, and Afg3l2 transcripts, encoding for the mitochondrial m-AAA protease.
    Sacco T; Boda E; Hoxha E; Pizzo R; Cagnoli C; Brusco A; Tempia F
    BMC Neurosci; 2010 Apr; 11():55. PubMed ID: 20426821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients.
    Kasher PR; De Vos KJ; Wharton SB; Manser C; Bennett EJ; Bingley M; Wood JD; Milner R; McDermott CJ; Miller CC; Shaw PJ; Grierson AJ
    J Neurochem; 2009 Jul; 110(1):34-44. PubMed ID: 19453301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and Genetic Heterogeneity of Adult Patients with Hereditary Spastic Paraplegia from Serbia.
    Perić S; Marković V; Candayan A; De Vriendt E; Momčilović N; Savić A; Dragašević-Mišković N; Svetel M; Stević Z; Božović I; Mesaroš Š; Drulović J; Basta I; Petrović I; Tamaš O; Mijajlović M; Novaković I; Sokić D; Jordanova A
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A founder mutation p.H701P identified as a major cause of SPG7 in Norway.
    Rydning SL; Wedding IM; Koht J; Chawla M; Øye AM; Sheng Y; Vigeland MD; Selmer KK; Tallaksen CM
    Eur J Neurol; 2016 Apr; 23(4):763-71. PubMed ID: 26756429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral nerve involvement in hereditary spastic paraplegia characterized by quantitative magnetic resonance neurography.
    Jacobi H; Weiler M; Sam G; Heiland S; Hayes JM; Bendszus M; Schüle R; Hayes JC
    Eur J Neurol; 2023 Aug; 30(8):2442-2452. PubMed ID: 37154411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons.
    Pozner T; Schray A; Regensburger M; Lie DC; Schlötzer-Schrehardt U; Winkler J; Turan S; Winner B
    Front Neurosci; 2018; 12():914. PubMed ID: 30574063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A.
    Zhu PP; Denton KR; Pierson TM; Li XJ; Blackstone C
    Hum Mol Genet; 2014 Nov; 23(21):5638-48. PubMed ID: 24908668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of mitochondrial function in hereditary spastic paraparesis.
    McDermott CJ; Taylor RW; Hayes C; Johnson M; Bushby KM; Turnbull DM; Shaw PJ
    Neuroreport; 2003 Mar; 14(3):485-8. PubMed ID: 12634509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel
    Votsi C; Ververis A; Nicolaou P; Christou YP; Christodoulou K; Zamba-Papanicolaou E
    Front Genet; 2021; 12():812640. PubMed ID: 35096021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
    Klebe S; Depienne C; Gerber S; Challe G; Anheim M; Charles P; Fedirko E; Lejeune E; Cottineau J; Brusco A; Dollfus H; Chinnery PF; Mancini C; Ferrer X; Sole G; Destée A; Mayer JM; Fontaine B; de Seze J; Clanet M; Ollagnon E; Busson P; Cazeneuve C; Stevanin G; Kaplan J; Rozet JM; Brice A; Durr A
    Brain; 2012 Oct; 135(Pt 10):2980-93. PubMed ID: 23065789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V.
    Sánchez-Ferrero E; Coto E; Beetz C; Gámez J; Corao AI; Díaz M; Esteban J; del Castillo E; Moris G; Infante J; Menéndez M; Pascual-Pascual SI; López de Munaín A; Garcia-Barcina MJ; Alvarez V;
    Clin Genet; 2013 Mar; 83(3):257-62. PubMed ID: 22571692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.